AJP - Endocrinology and Metabolism, Vol 260, Issue 3 E430-E435, Copyright © 1991 by American Physiological Society

ARTICLES

Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle

I. Raz, A. Katz and M. K. Spencer
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016.

The effect of epinephrine (E) infusion on insulin-mediated glucose metabolism in humans has been studied. Eight glucose-tolerant men were studied on two separate occasions: 1) during 120 min of euglycemic hyperinsulinemia (UH, approximately 5 mM; 40 mU.m-2.min-1); and 2) during UH while E was infused (UHE, 0.05 microgram.kg-1.min-1). Biopsies were taken from the quadriceps femoris muscle before and after each clamp. Glucose disposal, correcting for endogenous glucose production, was 36 +/- 3 and 18 +/- 2 (SE) mumol.kg fat-free mass (FFM)-1.min-1 during the last 40 min of UH and UHE, respectively (P less than 0.001). Nonoxidative glucose disposal (presumably glycogenesis) averaged 23.0 +/- 3.0 and 4.0 +/- 1.1 (P less than 0.001), whereas carbohydrate oxidation (which is proportional to glycolysis) averaged 13.1 +/- 1.4 and 15.3 +/- 1.1 mumol.kg FFM-1.min-1 (P less than 0.05) during UH and UHE, respectively. UHE resulted in significantly higher contents of UDP-glucose, hexose monophosphates, postphosphofructokinase intermediates, and glucose 1,6-bisphosphate (G-1,6-P2) in muscle (P less than 0.05-0.001), but there were no significant differences in high-energy phosphates or fructose 2,6-bisphosphate (F-2,6-P2) between treatments. Fractional activities of phosphorylase increased (P less than 0.01), and glycogen synthase decreased (P less than 0.001) during UHE. It is concluded that E inhibits insulin-mediated glycogenesis because of an inactivation of glycogen synthase and an activation of glycogenolysis. E also appears to inhibit insulin-mediated glucose utilization, at least partly, because of an increase in G-6-phosphate (which inhibits hexokinase) and enhances glycolysis by G-1,6-P2-, fructose 6-phosphate-, and F-1,6-P2-mediated activation of PFK.

This article has been cited by other articles:

				D. Aftab Guy, D. Sandoval, M. A. Richardson, D. Tate, and S. N. Davis Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E258 - E265. [Abstract] [Full Text] [PDF]

				L. M. Torres, J. Youngner, and A. Romani Role of glucose in modulating Mg2+ homeostasis in liver cells from starved rats Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G195 - G206. [Abstract] [Full Text] [PDF]

				D. A. Guy, D. Sandoval, M. A. Richardson, D. Tate, P. J. Flakoll, and S. N. Davis Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E178 - E186. [Abstract] [Full Text] [PDF]

				T. Borza, C. V. Iancu, E. Pike, R. B. Honzatko, and H. J. Fromm Variations in the Response of Mouse Isozymes of Adenylosuccinate Synthetase to Inhibitors of Physiological Relevance J. Biol. Chem., February 21, 2003; 278(9): 6673 - 6679. [Abstract] [Full Text] [PDF]

				R. P. Hoffman, C. A. Sinkey, J. M. Dopp, and B. G. Phillips Systemic and Local Adrenergic Regulation of Muscle Glucose Utilization During Hypoglycemia in Healthy Subjects Diabetes, March 1, 2002; 51(3): 734 - 742. [Abstract] [Full Text] [PDF]

				A. E. Halseth, D. P. Bracy, and D. H. Wasserman Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake J Appl Physiol, December 1, 1998; 85(6): 2305 - 2313. [Abstract] [Full Text] [PDF]

				R. M. O'Doherty, A. E. Halseth, D. K. Granner, D. P. Bracy, and D. H. Wasserman Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E287 - E296. [Abstract] [Full Text] [PDF]

				D. Laurent, K. F. Petersen, R. R. Russell, G. W. Cline, and G. I. Shulman Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E130 - E138. [Abstract] [Full Text] [PDF]